New eczema cream shows promise for kids in early safety trial
NCT ID NCT05186805
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times
Summary
This study tested a cream called tapinarof in 36 children aged 2 to 17 with moderate-to-severe eczema covering large body areas. The goal was to see how much of the drug enters the body and if it causes side effects. Researchers monitored safety through blood tests, vital signs, and skin reactions. The study was completed and provides early safety data for this potential treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dermavant Investigative Site
Thousand Oaks, California, 91320, United States
-
Dermavant Investigative Site
Centennial, Colorado, 80112, United States
-
Dermavant Investigative Site
Coral Gables, Florida, 33146, United States
-
Dermavant Investigative Site
Hialeah, Florida, 33016, United States
-
Dermavant Investigative Site
Miami Lakes, Florida, 33014, United States
-
Dermavant Investigative Site
Chicago, Illinois, 60611, United States
-
Dermavant Investigative Site
Summerville, South Carolina, 29445, United States
-
Dermavant Investigative Site
Houston, Texas, 77030, United States
-
Dermavant Investigative Site
San Antonio, Texas, 78213, United States
-
Dermavant Investigative Site
Calgary, Alberta, T3A 2N1, Canada
Conditions
Explore the condition pages connected to this study.